Investor Relations

OVERVIEW

FSD is a specialty, biotech pharmaceutical R&D company that aims to deliver growth and returns to shareholders through the development over time of multiple applications of the company’s lead compound FSD201, ultra-micronized PEA.

COMPANY INFORMATION

Legal Counsel
Bennet Jones, LLP

Auditor
MNP LLP

Fiscal Year End
December 31

Jurisdiction
Ontario, Canada

Transfer Agent
Computershare Trust Corporation

STOCK QUOTE

RECENT EVENTS

RECENT NEWS